Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
ENDOCYTE (NQ: ECYT)
14.02 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News
Press releases about ENDOCYTE
 
< Previous 1 2 Next >
Endocyte Appoints Scot L. Harper, Ph.D., as Vice President of Clinical Operations
May 07, 2013
from GlobeNewswire News Releases
Endocyte Reports First Quarter 2013 Financial Results and Business Update
May 02, 2013
from GlobeNewswire News Releases
Clinical Study Shows Involvement of Activated Macrophages in Osteoarthritis, Identified by Endocyte's Etarfolatide
April 25, 2013
from GlobeNewswire News Releases
Endocyte, Inc. Announces Annual Stockholders' Meeting
April 22, 2013
from GlobeNewswire News Releases
Endocyte Announces First Quarter 2013 Earnings Conference Call
April 18, 2013
from GlobeNewswire News Releases
Endocyte Announces Presentations at AACR Annual Meeting 2013
April 03, 2013
from GlobeNewswire News Releases
Endocyte to Present at the Future Leaders in the Biotech Industry Conference
April 01, 2013
from GlobeNewswire News Releases
Active Stocks in the Latest Trading Session: (NYSE:EXM), (NASDAQ:ECYT)
March 29, 2013
from SBWire Direct - Latest Press Releases
Free Research Reports on CHTP, ECYT, MFRM and RVLT Issued by the Bedford Report
March 28, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Endocyte to Webcast Investor and Analyst Day in New York City
March 18, 2013
from GlobeNewswire News Releases
Endocyte's Investigational Diagnostic Imaging Agent Etarfolatide Identifies Ovarian Cancer and Non-Small Cell Lung Cancer Patients Most Likely to Benefit From Folate Receptor-Targeted Treatment, New A
March 01, 2013
from GlobeNewswire News Releases
Endocyte to Present at Upcoming Conferences in March
February 26, 2013
from GlobeNewswire News Releases
Endocyte Reports Fourth Quarter and Year End 2012 Financial Results and Business Update
February 25, 2013
from GlobeNewswire News Releases
Endocyte to Present at Upcoming Conferences
February 07, 2013
from GlobeNewswire News Releases
Endocyte Announces Fourth Quarter and Full Year 2012 Earnings Conference Call
February 06, 2013
Company to Hold Investor and Analyst Day on March 22 Read More
from GlobeNewswire News Releases
Endocyte to Advance Development of EC1069, a PSMA-Targeted Small Molecule Drug Conjugate Therapy for Prostate Cancer
January 29, 2013
from GlobeNewswire News Releases
Dr. Lesley Russell Joins the Endocyte Board of Directors
January 08, 2013
from GlobeNewswire News Releases
Merck y Endocyte anuncia la aceptación para revisión de las solicitudes de autorización de comercialización europea de vintafolide y del diagnóstico asociado etarfolatide para el tratamiento del cánce
November 28, 2012
from Business Wire Spanish
Merck and Endocyte Announce Acceptance for Review of European Marketing Authorization Applications for Vintafolide and Companion Diagnostic Etarfolatide for Folate-Receptor Positive Platinum-Resistant
November 27, 2012
from Business Wire News Releases
Endocyte to Present at Upcoming Healthcare Conferences
November 06, 2012
from GlobeNewswire News Releases
Endocyte Reports Third Quarter 2012 Financial Results and Business Update
November 01, 2012
from GlobeNewswire News Releases
Endocyte Announces Third Quarter 2012 Earnings Conference Call
October 25, 2012
from GlobeNewswire News Releases
Data Published Identify the Folate Receptor as a Potential Biomarker for Targeted Therapies in a Majority of Lung Cancers
October 12, 2012
from GlobeNewswire News Releases
Endocyte Granted Orphan Drug Status for Folic Acid by European Commission
September 27, 2012
Orphan Designation in Place for all Components of Planned EU Marketing Authorization Applications Read More
from GlobeNewswire News Releases
Endocyte, Inc. to Present at Upcoming Health Care and Investor Conferences
August 28, 2012
from GlobeNewswire News Releases
Endocyte Announces Presentations at the 244th American Chemical Society Meeting & Exposition
August 14, 2012
from GlobeNewswire News Releases
Endocyte to Present at the Wedbush PacGrow Life Sciences Management Access Conference
August 07, 2012
from GlobeNewswire News Releases
New Published Data Demonstrate Endocyte's Targeted Small Molecule Drug Conjugate Approach Shows Promising Results in Polycystic Kidney Disease Model
August 03, 2012
Study Evaluating Folate-Conjugated Rapamycin Published Online in Journal of the American Society of Nephrology (JASN) Read More
from GlobeNewswire News Releases
Endocyte Reports Second Quarter 2012 Financial Results and Business Update
August 02, 2012
from GlobeNewswire News Releases
Endocyte Secures DOXIL(R) Supply to Support Ongoing Phase 3 PROCEED Trial in Ovarian Cancer
August 02, 2012
from GlobeNewswire News Releases
< Previous 1 2 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here